Physician profile
Melissa Porter
NPI 1124008602
$1,435.03
in general payments reported to CMS, 2019-2025
18 companies · $621 in 2025
The $621 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $120 · 2022: $54.55 · 2023: $291 · 2024: $348 · 2025: $621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $745 · Travel and Lodging: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $745.24 |
| Travel and Lodging | $514.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $570.31 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Organogenesis INC. | $269.34 | 2022-2025 | Puraply, Affinity |
| Boston Scientific Corporation | $98.90 | 2023-2024 | Varithena Administration Pack, Eluvia |
| Abbvie INC. | $97.15 | 2021 | |
| Baxter Healthcare | $97.07 | 2023 | Renal - Pd |
| Solventum Corporation | $37.03 | 2024 | Prevena |
| Kci USA, INC. | $35.13 | 2023 | Activ.A.C., Prevena |
| Smith+Nephew, INC. | $34.72 | 2024-2025 | Collagenase Santyl |
| Merck Sharp & Dohme LLC | $25.93 | 2025 | Keytruda, Lynparza |
| Biofrontera INC. | $23.82 | 2021-2022 | |
| Lemaitre Vascular, INC. | $22.78 | 2023 | Artegraft Vascular Graft |
| Astrazeneca Pharmaceuticals LP | $21.11 | 2023 | Lynparza |
| Blue Earth Diagnostics | $19.82 | 2024 | |
| Trisalus Life Sciences, INC. | $19.70 | 2024 | Trinav Infusion System |
| Telix Pharmaceuticals | $18.86 | 2024 | Illuccix |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $16.05 | 2022 | |
| Medtronic, INC. | $14.33 | 2023 | Ligasure |
| Sun Pharmaceutical Industries INC. | $12.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.